Skip to main content
. Author manuscript; available in PMC: 2021 Nov 1.
Published in final edited form as: Drug Saf. 2020 Nov;43(11):1073–1087. doi: 10.1007/s40264-020-00986-5

Table 2.

Identified Prevention Strategy Types and Subtypes

Prevention Strategy Subtype Example References
Training (P1.0) Training refreshers (P1.1) A51, A64, A82
Train on how and why (P1.2) A5, A64, A88
Nurse Involvement in Design and Evaluation (P2.0) Resource super users (P2.1) A5, A64
Nurse input for design (P2.2) A64, A81
Uniform Pump Brand/Function (P3.0) Standardize pump fleet (P3.1) A43, A94
Consistency Between Systems (P3.2) A64
Improve Communication & Reliability (P4.0) Redundant, independent medication checks by 2 people (P4.1) A45, A49
Medication review on transfer (P4.2) A43
Automation/Logic (P5.0) Automate medication titration (P5.1) A69
Logic for titrated drugs (P5.2) A8
Integrate pumps with lab or vital sign data (P5.3) A69
Automated error alert systems (P5.4) A24, A92
Technological Integration of Systems (P6.0) Barcode Scanner (BCMA) integrated with EHR (P6.1) A73, A95
Infusion Pumps Interfaced with EHR and BCMA (P6.2) A90, A92, A95
Standardize and Update Drug Libraries (P7.0) Limit and standardize medication concentrations (P7.1) A77, A86, A87
Include bolus doses in library (P7.2) A8
Scheduled library updates (P7.3) A62, A71
Increase Compliance (P8.0) Compliance with library, default to DERS, monitor compliance (P8.1) A35, A65, A84
Compliance with pump protocol (P8.2) A83
Simplify programming process to improve compliance (P8.3) A3
Decrease unnecessary warnings (P8.4) A8
Minimize workarounds (P8.5) A8, A88, A96
Interpump constraints – checking of infusion parameters between and across pumps (P8.6) A49
Hard limits on new smart pumps (P8.7) A43
Organizational Factors (P9.0) Eliminate Resource Constraints (P9.1) A64
No ‘One Size Fits All’ Policies (P9.2)– policies are specific and tailored to the needs of the patient population and clinical context A64
Policies and procedures to standardize processes and best practice (P9.3) A9, A19, A105
Limitation of Interruptions (P9.4) A10, A74
Human Factors/Quality Improvement (P10.0) Continuous QI with scheduled data review to improve pump use and compliance with DERS (P10.1) A6, A11, A53, A71
Use of Failure Mode & Effects Analyses (FMEA) (P10.2) A17, A31, A73, A98
Standardized medication concentrations (P10.3) A77, A86, A87
Human factors informed labels,
e.g., redesigning med labels to have higher readability, formatting consistent with pump programming info needs, color-coding, etc. (P10.4)
A87, A94
Checklists (P10.5) A49

Numbers in column 3 refer to the IDs for each article in the Appendix. Abbreviations: BCMA, barcode scanner; EHR, electronic health record; QI, quality improvement; FMEA, failure mode & effects analyses